Home > Insider Trading > Filing (0000880771-16-000181)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
880771	Sciclone Pharmaceuticals Inc	SCLN	Pharmaceutical Preparations (2834)	943116852

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555794	Lan Xie	950 Tower Lane, Suite 900 Foster City CA 94404	Vp Finance, China Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-08-12	9,333	$8.83	9,333	No	4	M	Direct
Common Stock	Disposition	2016-08-12	9,333	$10.36	0	No	4	S	Direct
Common Stock	Acquisiton	2016-08-12	7,500	$4.52	7,500	No	4	M	Direct
Common Stock	Disposition	2016-08-12	7,500	$10.36	0	No	4	S	Direct
Common Stock	Acquisiton	2016-08-12	2,812	$4.53	2,812	No	4	M	Direct
Common Stock	Disposition	2016-08-12	2,812	$10.36	0	No	4	S	Direct
Common Stock	Acquisiton	2016-08-12	12,187	$5.19	12,187	No	4	M	Direct
Common Stock	Disposition	2016-08-12	12,187	$10.36	0	No	4	S	Direct
Common Stock	Acquisiton	2016-08-12	1,000	$0.00	1,000	No	4	M	Direct
Common Stock	Disposition	2016-08-12	1,000	$10.41	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2016-08-12	7,500	$0.00	7,500	$4.52
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2016-08-12	2,812	$0.00	2,812	$4.53
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2016-08-12	12,187	$0.00	12,187	$5.19
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2016-08-12	9,333	$0.00	9,333	$8.83
Common Stock	Restricted Stock Unit	Acquisiton	2016-08-12	10,000	$0.00	10,000	$0.00
Common Stock	Restricted Stock Unit	Disposition	2016-08-12	1,000	$0.00	1,000	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,667	2024-03-14	No	4	M	Direct
2,500	2023-04-04	No	4	M	Direct
0	2022-08-01	No	4	M	Direct
18,667	2025-03-16	No	4	M	Direct
18,000		No	4	A	Direct
17,000		No	4	M	Direct

Footnotes

Granted under the Issuer's 2005 Equity Incentive Plan.
25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
Granted under the Issuer's 2015 Equity Incentive Plan.
Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.
Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.